We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Chattem, Inc. (MM) | NASDAQ:CHTT | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 93.49 | 0 | 00:00:00 |
From Dec 2019 to Dec 2024
French drug company Sanofi-Aventis Tuesday said it has completed its tender offer for all outstanding shares of common stock of Chattem, Inc (CHTT).
MAIN FACTS:
- As of the expiration time, approximately 18,611,072 shares of Chattem common stock were validly tendered and not withdrawn representing approximately 89.8% of the shares on a fully-diluted basis.
- All shares that were validly tendered and not validly withdrawn have been accepted for purchase.
- Chattem will become an indirect, wholly-owned subsidiary of Sanofi-Aventis.
- By Paris Bureau, Dow Jones Newswires; +331-4017-1740; djnews.paris@dowjones.com
1 Year Chattem, Inc. (MM) Chart |
1 Month Chattem, Inc. (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
